Avancerad sökning
Visar resultat 21 - 25 av 65 avhandlingar som matchar ovanstående sökkriterier.
21. Kinetics of HIV-1 drug resistance mutations in vivo
Sammanfattning : Antiretroviral therapy (ARV) exert a selective pressure on HIV-1 and may select viral drug resistant strains which have competitive advantage in the presence of the drug. Knowledge about the appearance and disappearance of these mutations is important when choosing ARV. LÄS MER
22. Analysis of the interaction between HIV-1 protease and inhibitors : Applications for drug discovery
Sammanfattning : The aims of this study were to identify and characterize inhibitors of HIV-l protease aspotential leads in a drug discovery process, and to develop improved methods for suchcharacterization. More than 300 inhibitors, including linear and cyclic peptidomimetictransition state analogs and Cu2+, were analyzed. LÄS MER
23. Genetic dynamics of HIV-1 : recombination, drug resistance and intrahost evolution
Sammanfattning : A striking characteristic of HIV is the enormous capacity of genetic variation. Frequent mutations, deletions, insertions and recombination events create a population of genetically related but non-identical viruses that is under constant change and ready to adapt to environmental changes. LÄS MER
24. Mucosal immune responses in HIV-1 exposed uninfected individuals
Sammanfattning : The development of HIV vaccines and immunotherapeutics remains hampered by our lack of understanding correlates of immune protection to infection and disease. The major (perhaps only) piece of evidence indicating that long-term, solid resistance to HIV infection is indeed possible comes from HIV exposed yet uninfected individuals (EUI). LÄS MER
25. Rational design and synthesis of protease inhibitors : targeting HIV-1, Malaria Plm I and II and Hepatitis C virus NS3 proteases
Sammanfattning : .... LÄS MER